NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
NovaBridge Biosciences
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026
$1.30+0.04 (+3.17%)
Close on Oct 19, 2026
NovaBridge Biosciences revenue by segment
By business segment
By product or service
By region
From the segment and revenue-disaggregation notes of NovaBridge Biosciences's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.